Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Toxic Reactions: Overview01:26

Toxic Reactions: Overview

1.3K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.3K
Pharmacovigilance01:19

Pharmacovigilance

1.2K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustainability awareness among European dry eye disease specialists.

European journal of ophthalmology·2026
Same author

Neuroinflammation and mononuclear phagocytes in glaucoma: From ocular pathogenesis to central visual pathway involvement - A comprehensive review.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Long-Term Evolution of Treatment Outcomes with Once-Daily Ciclosporin A 0.1% Cationic Emulsion in Patients with Dry Eye Disease and Severe Keratitis.

Ophthalmology and therapy·2026
Same author

Twelve-month outcomes after open bleb revision for Preserflo<sup>®</sup> microshunt bleb failure in refractory glaucoma patients.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

Efficacy and Safety of the Preserflo<sup>®</sup> Microshunt as a Standalone Procedure Versus Its Combination with Phacoemulsification.

Journal of clinical medicine·2026
Same author

A Systematic and Narrative Review of Safety and Complications in Minimally Invasive Glaucoma Surgery (MIGS) Between 2014-2024 [Response to Letter].

Clinical ophthalmology (Auckland, N.Z.)·2026

Related Experiment Video

Updated: Oct 25, 2025

Eye Irritation Test EIT for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial RhCE Tissue Model
10:13

Eye Irritation Test EIT for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial RhCE Tissue Model

Published on: August 23, 2015

38.9K

AOP and IATA applied to ocular surface toxicity.

Noémie Bonneau1, Christophe Baudouin2, Françoise Brignole-Baudouin3

  • 1Sorbonne Université, INSERM, CNRS, IHU FOReSight, Institut de La Vision, 75012, Paris, France; HORUS PHARMA, 06700, Saint-Laurent-du-Var, France.

Regulatory Toxicology and Pharmacology : RTP
|August 4, 2021
PubMed
Summary

New integrated approaches to testing and assessment (IATA) and adverse outcome pathways (AOP) are proposed to replace the rabbit Draize test for ocular toxicity. These methods aim to reduce animal testing for pharmaceutical compounds.

Keywords:
AOPIATAOECDOcular surfaceToxic exposureToxicity-induced dry eye (TIDE)

More Related Videos

High Throughput SiRNA Screening for Chloropicrin and Hydrogen Fluoride-Induced Cornea Epithelial Cell Injury
14:20

High Throughput SiRNA Screening for Chloropicrin and Hydrogen Fluoride-Induced Cornea Epithelial Cell Injury

Published on: June 16, 2018

6.0K
Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery
07:45

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

3.6K

Related Experiment Videos

Last Updated: Oct 25, 2025

Eye Irritation Test EIT for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial RhCE Tissue Model
10:13

Eye Irritation Test EIT for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial RhCE Tissue Model

Published on: August 23, 2015

38.9K
High Throughput SiRNA Screening for Chloropicrin and Hydrogen Fluoride-Induced Cornea Epithelial Cell Injury
14:20

High Throughput SiRNA Screening for Chloropicrin and Hydrogen Fluoride-Induced Cornea Epithelial Cell Injury

Published on: June 16, 2018

6.0K
Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery
07:45

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

3.6K

Area of Science:

  • Toxicology
  • Ocular toxicology
  • Regulatory science

Background:

  • The rabbit Draize test has been the standard for assessing ocular toxicity and irritation of pharmaceuticals.
  • The Organisation for Economic Co-operation and Development (OECD) advocates for alternative methods to minimize animal testing.
  • Current models are insufficient to capture the full biological response, necessitating integrated approaches.

Purpose of the Study:

  • To describe OECD tools for developing alternative ocular toxicity testing methods.
  • To propose novel adverse outcome pathways (AOP) for the ocular surface.
  • To present an integrated approach to testing and assessment (IATA) for toxicity-induced dry eye (TIDE).

Main Methods:

  • Review and description of existing OECD regulatory tools.
  • Conceptualization of AOPs for ocular surface toxicity.
  • Development of an IATA framework for TIDE.

Main Results:

  • The commentary outlines OECD-endorsed tools for alternative testing strategies.
  • Original AOP frameworks for ocular surface toxicity are proposed.
  • A novel IATA for TIDE is presented, integrating multiple test methods.

Conclusions:

  • Integrated Approaches to Testing and Assessment (IATA) and AOPs are crucial for robust ocular toxicity data.
  • The proposed frameworks offer a path towards reducing and replacing animal testing in pharmaceutical safety evaluation.
  • These approaches support the development of reliable alternatives for ocular toxicity assessment, specifically for TIDE.